Accuvest Global Advisors Sells 2,581 Shares of KKR & Co. Inc. (NYSE:KKR)

Key Points

• Accuvest Global Advisors reduced its stake in KKR & Co. Inc. by 10.1%, selling 2,581 shares during the first quarter, leaving it with 22,898 shares valued at $2.6 million.
• Major shareholder Genetic Disorder L.P. sold 6 million shares at an average price of $34.20, reducing their ownership by 31.15% and retaining 13.26 million shares valued at approximately $453.5 million.
• KKR recently declared an increased quarterly dividend of $0.185 per share, compared to its previous dividend of $0.18, reflecting a commitment to returning value to shareholders.

Accuvest Global Advisors reduced its position in KKR & Co. Inc. (NYSE:KKR - Free Report) by 10.1% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 22,898 shares of the asset manager's stock after selling 2,581 shares during the quarter. KKR & Co. Inc. makes up about 2.3% of Accuvest Global Advisors' portfolio, making the stock its 15th largest position. Accuvest Global Advisors' holdings in KKR & Co. Inc. were worth $2,647,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. McIlrath & Eck LLC acquired a new position in KKR & Co. Inc. during the fourth quarter worth $26,000. Mascagni Wealth Management Inc. bought a new position in KKR & Co. Inc. during the fourth quarter worth about $31,000. Ameriflex Group Inc. bought a new position in KKR & Co. Inc. during the fourth quarter worth about $46,000. Mountain Hill Investment Partners Corp. bought a new position in KKR & Co. Inc. during the first quarter worth about $38,000. Finally, GW&K Investment Management LLC boosted its position in shares of KKR & Co. Inc. by 44.6% in the first quarter. GW&K Investment Management LLC now owns 360 shares of the asset manager's stock valued at $42,000 after acquiring an additional 111 shares during the period. 76.26% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on KKR shares. Keefe, Bruyette & Woods raised their price objective on shares of KKR & Co. Inc. from $155.00 to $162.00 and gave the company an "outperform" rating in a research report on Monday, August 4th. Barclays lifted their price target on shares of KKR & Co. Inc. from $155.00 to $165.00 and gave the stock an "overweight" rating in a research note on Monday, August 4th. HSBC downgraded shares of KKR & Co. Inc. from a "buy" rating to a "hold" rating and set a $142.00 price target on the stock. in a research note on Wednesday, July 9th. Morgan Stanley raised shares of KKR & Co. Inc. from an "equal weight" rating to an "overweight" rating and lifted their price target for the stock from $120.00 to $150.00 in a research note on Wednesday, May 14th. Finally, Wall Street Zen raised shares of KKR & Co. Inc. from a "strong sell" rating to a "hold" rating in a research note on Saturday, August 2nd. Five equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $157.73.

Insider Buying and Selling at KKR & Co. Inc.

In other news, major shareholder Genetic Disorder L.P. Kkr sold 6,000,000 shares of the business's stock in a transaction on Monday, May 12th. The shares were sold at an average price of $34.20, for a total transaction of $205,200,000.00. Following the sale, the insider owned 13,260,971 shares in the company, valued at approximately $453,525,208.20. The trade was a 31.15% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Chairman George R. Roberts sold 809,906 shares of the business's stock in a transaction on Thursday, August 7th. The shares were sold at an average price of $144.25, for a total transaction of $116,828,940.50. Following the sale, the chairman owned 81,361,978 shares in the company, valued at approximately $11,736,465,326.50. This trade represents a 0.99% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 9,281,394 shares of company stock worth $618,358,033. Corporate insiders own 39.34% of the company's stock.

KKR & Co. Inc. Trading Up 0.4%

NYSE KKR traded up $0.63 during trading on Friday, hitting $142.82. The company had a trading volume of 2,163,488 shares, compared to its average volume of 3,545,484. KKR & Co. Inc. has a one year low of $86.15 and a one year high of $170.40. The company has a market cap of $127.20 billion, a price-to-earnings ratio of 66.43, a price-to-earnings-growth ratio of 1.53 and a beta of 1.87. The company has a current ratio of 0.08, a quick ratio of 0.08 and a debt-to-equity ratio of 0.77. The company's fifty day moving average is $135.44 and its 200-day moving average is $127.77.

KKR & Co. Inc. (NYSE:KKR - Get Free Report) last announced its earnings results on Thursday, July 31st. The asset manager reported $1.18 EPS for the quarter, beating analysts' consensus estimates of $1.14 by $0.04. KKR & Co. Inc. had a net margin of 12.95% and a return on equity of 6.42%. The firm had revenue of $1.86 billion for the quarter, compared to analysts' expectations of $1.81 billion. During the same quarter in the previous year, the business posted $1.09 EPS. On average, sell-side analysts predict that KKR & Co. Inc. will post 5.19 earnings per share for the current year.

KKR & Co. Inc. Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, August 26th. Stockholders of record on Monday, August 11th will be issued a dividend of $0.185 per share. This represents a $0.74 dividend on an annualized basis and a dividend yield of 0.5%. This is a boost from KKR & Co. Inc.'s previous quarterly dividend of $0.18. KKR & Co. Inc.'s payout ratio is 34.42%.

KKR & Co. Inc. Company Profile

KKR & Co, Inc operates as an investment firm. It offers alternative asset management as well as capital markets and insurance solutions. The firm's business segments include Asset Management and Insurance Business. The Asset Management segment engages in providing private equity, real assets, credit and liquid strategies, capital markets, and principal activities.